linezolidceftazidime-avibactamcolistinoxazolidinonesCombination therapynosocomial infectionsurinary tract infectionsmultidrug-resistant infections
…D/1000 patient-days for colistin, 2.3 DDD/1000 patient-days for linezolid, and 2.8 DDD/1000 patient-days for ceftazidime-avibactam.Conclu…